Kintara Therapeutics Inc (KTRA)
0.3267
+0.03
(+9.48%)
USD |
NASDAQ |
Jun 26, 16:00
0.336
+0.01
(+2.85%)
After-Hours: 20:00
Kintara Therapeutics Cash from Operations (Quarterly): -2.30M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.30M |
| December 31, 2023 | -2.117M |
| September 30, 2023 | -1.317M |
| June 30, 2023 | -1.508M |
| March 31, 2023 | -1.827M |
| December 31, 2022 | -2.161M |
| September 30, 2022 | -6.369M |
| June 30, 2022 | -4.992M |
| March 31, 2022 | -5.223M |
| December 31, 2021 | -5.104M |
| September 30, 2021 | -5.073M |
| June 30, 2021 | -4.689M |
| March 31, 2021 | -4.63M |
| December 31, 2020 | -5.431M |
| September 30, 2020 | -4.11M |
| June 30, 2020 | -2.578M |
| March 31, 2020 | -1.373M |
| December 31, 2019 | -1.711M |
| September 30, 2019 | -2.266M |
| June 30, 2019 | -1.813M |
| March 31, 2019 | -1.465M |
| December 31, 2018 | -0.965M |
| September 30, 2018 | -2.085M |
| June 30, 2018 | -2.533M |
| March 31, 2018 | -2.812M |
| Date | Value |
|---|---|
| December 31, 2017 | -2.133M |
| September 30, 2017 | -2.373M |
| June 30, 2017 | -3.449M |
| March 31, 2017 | -1.508M |
| December 31, 2016 | -1.449M |
| September 30, 2016 | -1.613M |
| June 30, 2016 | -1.554M |
| March 31, 2016 | -0.9569M |
| December 31, 2015 | -1.233M |
| September 30, 2015 | -1.402M |
| June 30, 2015 | -0.8086M |
| March 31, 2015 | -0.9791M |
| December 31, 2014 | -1.094M |
| September 30, 2014 | -0.9715M |
| March 31, 2014 | -0.8845M |
| December 31, 2013 | -1.034M |
| September 30, 2013 | -1.112M |
| June 30, 2013 | -1.250M |
| March 31, 2013 | -2.124M |
| December 31, 2012 | -0.0016M |
| September 30, 2012 | -0.0042M |
| June 30, 2012 | -0.001M |
| March 31, 2012 | -0.0031M |
| December 31, 2011 | -0.0084M |
| September 30, 2011 | 0.0011M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.369M
Minimum
Sep 2022
-1.317M
Maximum
Sep 2023
-3.330M
Average
-2.439M
Median
Cash from Operations (Quarterly) Benchmarks
| ARCA biopharma Inc | -1.528M |
| Vanda Pharmaceuticals Inc | 7.569M |
| Asensus Surgical Inc | -14.01M |
| Catalent Inc | 12.00M |
| CEL-SCI Corp | -4.528M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 7.993M |
| Free Cash Flow | -7.262M |
| Free Cash Flow Per Share (Quarterly) | -0.0516 |
| Free Cash Flow Yield | -170.0% |